RADIOMUNE PHARMA

RADIOMUNE PHARMA

SIREN 980195994

Active

What the register says about RADIOMUNE PHARMA

RADIOMUNE PHARMA is registered under SIREN number 980195994. Its registered office is located at 163 Avenue de Luminy Zone Luminy Biotech Entreprises, 13009 Marseille 9e Arrondissement. The company was founded on 03/10/2023. It declares that it operates in the Recherche-développement en autres sciences physiques et naturelles sector. It is currently listed as active in the national business register.

BODACC has published 6 notices concerning it, the most recent dated 31/10/2026. An account filing makes public the annual accounts submitted to the court registry: it confirms that accounting records exist and have been filed, nothing more. It says nothing about revenue, profit, or the commercial health of the company. A modification signals a declared change: management, registered office, activity, or share capital.

2 directors are published in the register. They are BÉCHARD, BECOUZE.

Identity : RADIOMUNE PHARMA

RADIOMUNE PHARMA

SIREN
980195994
Head office SIRET
98019599400010
Legal form
SAS (société par actions simplifiée)
NAF code
72.19Z · Recherche-développement en autres sciences physiques et naturelles
Address
163 Avenue de Luminy Zone Luminy Biotech Entreprises, 13009 Marseille 9e Arrondissement
Creation date
10/03/2023
Category
PME
Status
Active
VAT
FR14980195994
Filing
07/14/2026
Closing
12/31/2025

Recent notices (6)

All legal notices

Web presence : RADIOMUNE PHARMA

The company's official website, its networks and online contact details.

Web presence : RADIOMUNE PHARMA

Recent notices : RADIOMUNE PHARMA

The BODACC notices published for this company.

Directors : RADIOMUNE PHARMA

The people who run or have run the company.

Relations : RADIOMUNE PHARMA

The relationship graph: linked notices, people and companies.

Public contracts : RADIOMUNE PHARMA

The public contracts won by the company.

No won public contract found for this company

FAQ & filings : RADIOMUNE PHARMA

Frequently asked questions and the company's filing history.

Frequently asked questions : RADIOMUNE PHARMA